Total Payments
$630.51
2024 Payments
$347.94
Companies
9
Transactions
16
Medicare Patients
2,419
Medicare Billing
$370,708
Payment Breakdown by Category
Food & Beverage$615.51 (97.6%)
Travel$15.00 (2.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $615.51 | 15 | 97.6% |
| Travel and Lodging | $15.00 | 1 | 2.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $403.24 | 5 | $0 (2024) |
| Boston Scientific Corporation | $55.39 | 2 | $0 (2024) |
| Abbott Laboratories | $51.53 | 3 | $0 (2020) |
| ABBVIE INC. | $32.71 | 1 | $0 (2024) |
| Nevro Corp. | $22.06 | 1 | $0 (2020) |
| SI-BONE, INC. | $20.41 | 1 | $0 (2024) |
| Bioventus LLC | $18.44 | 1 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.59 | 1 | $0 (2020) |
| Kowa Pharmaceuticals America, Inc. | $12.14 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $347.94 | 7 | Medtronic, Inc. ($239.43) |
| 2023 | $148.81 | 1 | Medtronic, Inc. ($148.81) |
| 2022 | $12.14 | 1 | Kowa Pharmaceuticals America, Inc. ($12.14) |
| 2021 | $33.44 | 2 | Bioventus LLC ($18.44) |
| 2020 | $48.11 | 3 | Nevro Corp. ($22.06) |
| 2019 | $40.07 | 2 | Abbott Laboratories ($40.07) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $36.38 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 11/06/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $182.14 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/30/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 09/10/2024 | SI-BONE, INC. | — | Food and Beverage | Cash or cash equivalent | $20.41 | General |
| 05/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $32.71 | General |
| Category: NEUROSCIENCE | ||||||
| 04/16/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $27.58 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 04/09/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $29.71 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 07/28/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $148.81 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/01/2022 | Kowa Pharmaceuticals America, Inc. | Seglentis (Drug) | Food and Beverage | Cash or cash equivalent | $12.14 | General |
| Category: Pain Management | ||||||
| 11/05/2021 | Medtronic, Inc. | INTELLIS (Device) | Travel and Lodging | In-kind items and services | $15.00 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 04/22/2021 | Bioventus LLC | Durolane (Device) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Orthopedics/Orthopedic Surgery | ||||||
| 11/13/2020 | Nevro Corp. | Senza Spinal Cord Stimulation System (Device) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: Spinal Cord Stimulator | ||||||
| 03/23/2020 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $11.46 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 02/03/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/26/2019 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 11/07/2019 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 515 | 1,245 | $1.4M | $81,400 |
| 2022 | 18 | 669 | 2,222 | $1.6M | $112,246 |
| 2021 | 20 | 812 | 1,859 | $1.7M | $123,636 |
| 2020 | 10 | 423 | 852 | $631,616 | $53,426 |
Total Patients
2,419
Total Services
6,178
Medicare Billing
$370,708
Procedure Codes
64
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 167 | 535 | $695,500 | $48,350 | 7.0% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 27 | 35 | $41,300 | $5,371 | 13.0% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 63 | 77 | $60,830 | $4,689 | 7.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 32 | 32 | $54,080 | $4,180 | 7.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 46 | 59 | $53,690 | $4,088 | 7.6% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 27 | 32 | $27,616 | $3,588 | 13.0% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 21 | 28 | $124,564 | $2,788 | 2.2% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 12 | 19 | $60,825 | $1,838 | 3.0% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 20 | 22 | $104,536 | $1,643 | 1.6% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2023 | 15 | 17 | $50,631 | $1,505 | 3.0% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 11 | 18 | $29,808 | $1,057 | 3.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Facility | 2023 | 18 | 23 | $27,129 | $945.36 | 3.5% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 12 | 17 | $19,214 | $772.16 | 4.0% |
| 77002 | Fluoroscopic guidance for needle placement | Facility | 2023 | 18 | 23 | $11,613 | $491.74 | 4.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 14 | 88 | $6,336 | $70.82 | 1.1% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 12 | 220 | $7,920 | $21.57 | 0.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 181 | 635 | $825,500 | $59,808 | 7.2% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 42 | 58 | $68,440 | $8,803 | 12.9% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 83 | 125 | $98,750 | $7,670 | 7.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 57 | 57 | $96,330 | $6,280 | 6.5% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 36 | 50 | $43,150 | $5,648 | 13.1% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2022 | 25 | 29 | $137,798 | $5,579 | 4.0% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2022 | 17 | 20 | $88,974 | $4,142 | 4.7% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2022 | 19 | 21 | $62,544 | $3,319 | 5.3% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2022 | 11 | 14 | $44,818 | $2,749 | 6.1% |
About Dr. Shawn Murphy, D.O
Dr. Shawn Murphy, D.O is a Pain Medicine healthcare provider based in Wesley Chapel, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2008. The National Provider Identifier (NPI) number assigned to this provider is 1811151483.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shawn Murphy, D.O has received a total of $630.51 in payments from pharmaceutical and medical device companies, with $347.94 received in 2024. These payments were reported across 16 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($615.51).
As a Medicare-enrolled provider, Murphy has provided services to 2,419 Medicare beneficiaries, totaling 6,178 services with total Medicare billing of $370,708. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Other Specialties Pain Medicine
- Location Wesley Chapel, FL
- Active Since 07/14/2008
- Last Updated 10/10/2024
- Taxonomy Code 2081P2900X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1811151483
Products in Payments
- INTELLIS ADAPTIVESTIM (Device) $388.24
- WaveWriter Alpha Prime 16 (Device) $55.39
- Proclaim Family of SCS IPGs (Device) $51.53
- UBRELVY (Drug) $32.71
- Senza Spinal Cord Stimulation System (Device) $22.06
- Durolane (Device) $18.44
- INTELLIS (Device) $15.00
- RELISTOR (Drug) $14.59
- Seglentis (Drug) $12.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.